CannaPowder, Inc. (CAPD) Financial Statements (2024 and earlier)
Company Profile
Business Address |
20 RAOUL WALLENBERG ST., TEL AVIV,, 6971916 |
State of Incorp. | UT |
Fiscal Year End | December 31 |
Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
12/31/2019 | 12/31/2018 | |||
---|---|---|---|---|
ASSETS | ||||
Current Assets | ||||
Cash, cash equivalents, and short-term investments | 714,409 | |||
Cash and cash equivalents | 606,245 | |||
Short-term investments | 108,164 | |||
Prepaid expense | 12,847 | |||
Deposits current assets | ||||
Total current assets: | 727,256 | |||
Noncurrent Assets | ||||
TOTAL ASSETS: | 727,256 | |||
LIABILITIES AND EQUITY | ||||
Liabilities | ||||
Current Liabilities | ||||
Accounts payable and accrued liabilities, including: | 25,159 | |||
Interest and dividends payable | ||||
Other undisclosed accounts payable and accrued liabilities | 25,159 | |||
Due to related parties | ||||
Total current liabilities: | 25,159 | |||
Noncurrent Liabilities | ||||
Total liabilities: | 25,159 | |||
Equity | ||||
Equity, attributable to parent, including: | 702,097 | |||
Common stock | 105 | |||
Additional paid in capital | 4,472,095 | |||
Accumulated other comprehensive loss | (173,832) | |||
Accumulated deficit | (3,573,378) | |||
Other undisclosed equity, attributable to parent | (22,893) | |||
Total equity: | 702,097 | |||
TOTAL LIABILITIES AND EQUITY: | 727,256 |
Income Statement (P&L) (USD)
12/31/2019 | 12/31/2018 | ||
---|---|---|---|
Operating expenses | (3,488,107) | ||
Operating loss: | (3,488,107) | ||
Nonoperating income (expense) | 27,075 | ||
Investment income, nonoperating | 37,893 | ||
Loss, foreign currency transaction, before tax | (10,818) | ||
Interest and debt expense | |||
Loss from continuing operations: | (3,461,032) | ||
Loss before gain (loss) on sale of properties: | (3,461,032) | ||
Other undisclosed net income (loss) | (27,075) | ||
Net loss: | (3,488,107) | ||
Net income attributable to noncontrolling interest | |||
Other undisclosed net income attributable to parent | 37,893 | ||
Net loss available to common stockholders, diluted: | (3,450,214) |
Comprehensive Income (USD)
12/31/2019 | 12/31/2018 | ||
---|---|---|---|
Net loss: | (3,488,107) | ||
Other undisclosed comprehensive loss | (177,185) | ||
Comprehensive loss: | (3,665,292) | ||
Comprehensive income, net of tax, attributable to noncontrolling interest | 37,893 | ||
Other undisclosed comprehensive income, net of tax, attributable to parent | |||
Comprehensive loss, net of tax, attributable to parent: | (3,627,399) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.